共 63 条
[44]
The Effect of Salient Reputational Threats on the Pace of FDA Enforcement
[J].
GOVERNANCE-AN INTERNATIONAL JOURNAL OF POLICY ADMINISTRATION AND INSTITUTIONS,
2013, 26 (01)
:31-61
[45]
Organizational Reputations and the Observability of Public Warnings in 10 Pharmaceutical Markets
[J].
GOVERNANCE-AN INTERNATIONAL JOURNAL OF POLICY ADMINISTRATION AND INSTITUTIONS,
2011, 24 (03)
:557-582
[46]
Organizational Reputation and Jurisdictional Claims: The Case of the US Food and Drug Administration
[J].
GOVERNANCE-AN INTERNATIONAL JOURNAL OF POLICY ADMINISTRATION AND INSTITUTIONS,
2010, 23 (01)
:133-159
[47]
MARCUS AA, 1991, ACAD MANAGE J, V34, P281, DOI 10.5465/256443
[49]
Pfeffer Jeffery., 1981, RES ORG BEHAV, V3, P1
[50]
Podolny JoelM., 2005, STATUS SIGNALS